Compare KSS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSS | INMD |
|---|---|---|
| Founded | 1962 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 854.5M |
| IPO Year | 1995 | 2018 |
| Metric | KSS | INMD |
|---|---|---|
| Price | $17.28 | $14.92 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 15 | 5 |
| Target Price | $15.31 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 3.9M | 410.4K |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ 142.86 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | $0.21 | $3.26 |
| P/E Ratio | $14.85 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.38 | $12.72 |
| 52 Week High | $25.22 | $16.74 |
| Indicator | KSS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 39.86 |
| Support Level | $16.19 | $13.27 |
| Resistance Level | $20.09 | $15.24 |
| Average True Range (ATR) | 0.99 | 0.19 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 20.04 | 20.83 |
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.